Founded in 1979, Sanderling Ventures is amongst the oldest and most established North American venture firms focused exclusively on biomedical investing. We invest in therapeutics, medical devices and information health.
Sanderling has consistently high rates of return across multiple vintage years with multiple top quartile funds.
In Canada, Sanderling utilizes Therillia Development Co., a Sanderling portfolio company based in Montreal, to manage the development of therapeutic assets held by other Sanderling portfolio companies. This model of “active management” utilizes the expertise of Therillia’s seasoned drug development team and has been successful in advancing multiple projects in a cost-effective manner.
1010 Sherbrooke St. W., Suite 408
Montreal , Qc, Canada
In business since
- United States
Rosa Di Pierro
- Fund of funds
Nature of the financing / Investment activity
- Life Sciences